Overview
Jatropha poisoning occurs after ingestion, inhalation, or skin contact with toxic parts of the Jatropha curcas plant (commonly called âpurging nut,â âphysic nut,â or âSamaâ). The plant is native to the tropical Americas but is now cultivated worldwide for bioâfuel, animal feed, and ornamental purposes. Its seeds, seed oil, leaves, latex, and bark contain a mixture of toxic compoundsâmost notably the proteinâŻcurcin and the diterpenoidâŻjatrophaginâthat can cause severe gastrointestinal, renal, and cardiovascular disturbances.
While Jatropha is increasingly grown in Asia, Africa, and Latin America, poisoning remains relatively uncommon in highâincome countries. In India, the National Poisons Information Centre (NPIC) reported an average of 20â30 cases per year between 2015 and 2020, most of which involved accidental ingestion by children or intentional selfâharm. In subâSaharan Africa, communityâbased surveys have documented up to 5âŻ% of households with at least one episode of âseed poisoningâ during the past decade, highlighting the plantâs publicâhealth relevance in rural settings.
Anyone who eats or chews any part of the plantâespecially the seeds, which are the most toxicâcan develop poisoning. Children are disproportionately affected because seeds are often mistaken for nuts or candy, while agricultural workers, herbalâmedicine users, and members of traditionalâmedicine communities are at higher occupational risk.
Symptoms
Clinical manifestations develop within minutes to several hours after exposure and follow a pattern that reflects the toxic constituents of the plant.
- Gastroâintestinal (GI) irritation â nausea, vomiting (often projectile), abdominal cramping, and watery diarrhea. The vomiting may be profuse and contain blood (hematemesis) in severe cases.
- Oral cavity irritation â burning sensation, swelling, or ulceration of the lips, tongue, and throat.
- Neurologic effects â dizziness, headache, weakness, and in rare cases seizures or coma due to severe electrolyte imbalance.
- Renal involvement â oliguria or anuria, flank pain, and later development of acute tubular necrosis (ATN) leading to acute kidney injury (AKI).
- Cardiovascular signs â tachycardia, hypotension, and in massive ingestions, arrhythmias.
- Hepatic injury â elevated transaminases; clinically apparent hepatitis is uncommon but reported in massive overdose.
- Dermatitis (after skin contact) â erythema, pruritus, vesicle formation, and possible secondary infection.
Symptoms are doseâdependent. A single seed may cause only mild GI upset, while ingestion of 5â10 seeds can precipitate lifeâthreatening AKI.
Causes and Risk Factors
What causes Jatropha poisoning?
The toxicity of Jatropha derives from several bioactive compounds:
- Curcin (Ricinâlike protein) â inhibits protein synthesis causing cellular death, especially in the intestinal mucosa and renal tubules.
- Jatrophagin A & B (Diterpenoid esters) â irritants that increase intestinal secretions and vascular permeability.
- Phorbol esters â promote inflammation and may trigger tumorâpromotion pathways (relevant for chronic exposure).
- Latex & alkaloids â contribute to skin irritation and respiratory symptoms.
Who is at higher risk?
- Children <5âŻyears â attracted by the seedâs shape and color.
- Agricultural workers â handling seeds for oil extraction or bioâfuel production without protective gear.
- Traditionalâmedicine practitioners â may use leaves or seed extracts for âpurgingâ or âdetoxâ rituals.
- Individuals with preâexisting kidney disease â are more vulnerable to AKI.
- People with limited healthâliteracy â may not recognize toxicity signs and delay care.
Diagnosis
There is no single laboratory test that definitively confirms Jatropha poisoning; diagnosis relies on a combination of clinical history, physical examination, and targeted investigations.
Key diagnostic steps
- History taking â ascertain exposure (type of plant part, estimated amount, time since ingestion). Ask about use of traditional remedies.
- Physical exam â evaluate for oral lesions, signs of dehydration, abdominal tenderness, and neurologic status.
- Basic laboratory panel:
- Complete blood count (CBC) â may show leukocytosis.
- Electrolytes, blood urea nitrogen (BUN), creatinine â to assess renal function.
- Liver function tests (AST, ALT, bilirubin) â monitor hepatic involvement.
- Arterial blood gas â detect metabolic acidosis from vomiting/diarrhea.
- Urinalysis â granular casts, hematuria, or proteinuria suggest renal tubular damage.
- Imaging â abdominal ultrasound may reveal renal enlargement or obstructive uropathy; chest Xâray if respiratory distress is present.
- Special tests (when available) â enzymeâlinked immunosorbent assay (ELISA) for curcin or massâspectrometry detection of diterpenoids in blood or urine. These are primarily research tools and not routine.
Because the clinical picture often mimics other causes of acute gastroenteritis or poisoning, a high index of suspicion is essential, especially in regions where Jatropha grows.
Treatment Options
Management is largely supportive, aimed at preventing absorption of toxins, correcting fluid/electrolyte loss, and protecting organ function.
Immediate measures
- Decontamination â if the patient presents within 1âŻhour of ingestion and is alert, administer activated charcoal (1âŻg/kg, max 50âŻg). Do not induce emesis.
- Gastric lavage â may be considered within 30âŻminutes for massive ingestions, but carries aspiration risk.
Fluid and electrolyte replacement
Intravenous isotonic crystalloids (e.g., normal saline or lactated Ringerâs) are given to counteract vomiting/diarrheaâinduced dehydration. Monitor serum electrolytes every 4â6âŻhours; replace potassium and magnesium as needed.
Renal support
- Monitoring â hourly urine output; target >0.5âŻmL/kg/h.
- Hemodialysis â indicated for refractory hyperkalemia, severe metabolic acidosis, or oliguria/anuria persisting >48âŻh.
Pharmacologic therapies
- Antiemetics â ondansetron 4â8âŻmg IV/PO q8h.
- Antidiarrheals â loperamide may be used after the acute phase; avoid in the first 24âŻh if there is a risk of ileus.
- Renal protective agents â Nâacetylcysteine (NAC) 150âŻmg/kg loading dose, then 50âŻmg/kg every 4âŻh for 24âŻh, has shown modest benefit in experimental models, but clinical evidence is limited.
- Pain control â acetaminophen (avoid in highâdose hepatic injury) or opioids as needed.
Supportive care
Oxygen supplementation for hypoxia, temperature control, and close cardiac monitoring are essential for severe cases.
Longâterm considerations
Patients who develop AKI should have followâup renal function tests for at least 6âŻmonths, as some may progress to chronic kidney disease (CKD).
Living with Jatropha Poisoning
Survivors may face lingering health issues and lifestyle adjustments.
- Renal followâup â schedule nephrology visits at 1, 3, and 6âŻmonths postâdischarge. Maintain adequate hydration (â„2âŻL/day unless contraindicated).
- Dietary modifications â limit highâprotein meals while kidneys recover; focus on lowâsalt, lowâpotassium foods if renal function remains impaired.
- Medication review â avoid nephrotoxic drugs (NSAIDs, certain antibiotics) until kidney function normalises.
- Psychological support â intentional ingestion is linked to underlying mentalâhealth disorders. Referral to counseling or psychiatry is advised.
- Education of family members â ensure childrenâs caregivers recognize the plant and keep seeds out of reach.
Prevention
Because exposure is largely preventable, communityâlevel interventions are effective.
- Public education â schoolâbased programs about the dangers of âpurging nuts.â Posters in rural health clinics illustrating the plant.
- Agricultural safety â provide workers with gloves, masks, and goggles during seed collection and oil pressing; establish designated âtoxicâplantâ disposal pits.
- Regulation of traditional medicines â encourage health authorities to monitor and certify herbal products; discourage unverified oral use of Jatropha extracts.
- Safe storage â keep seeds in locked containers, separate from food supplies.
- Childproofing â use safety caps on containers, place toxic plant material out of childrenâs reach.
Complications
If not promptly treated, Jatropha poisoning can lead to serious, sometimes irreversible, sequelae.
- Acute Kidney Injury (AKI) â the most frequent severe outcome; may require temporary dialysis.
- Chronic Kidney Disease (CKD) â up to 15âŻ% of patients with severe AKI develop persistent renal impairment (based on a 2019 caseâseries in Ghana).
- Severe electrolyte disturbances â hyperkalemia leading to cardiac arrhythmias.
- Hypovolemic shock â from profuse vomiting/diarrhea.
- Gastrointestinal perforation â rare, but reported in children with massive ingestion.
- Hepatic injury â usually selfâlimited but may progress to fulminant hepatitis in massive doses.
- Neurologic deficits â seizures or persistent weakness secondary to metabolic derangements.
- Mentalâhealth impact â intentional ingestion can be a marker for depression or suicidal ideation.
When to Seek Emergency Care
- Severe or persistent vomiting (especially if bloodâstained)
- Profuse watery diarrhea leading to dehydration
- Sudden loss of urine or markedly reduced urine output
- Severe abdominal pain or swelling
- Chest pain, palpitations, or fainting spells
- Difficulty breathing, wheezing, or throat swelling
- Confusion, seizures, or unresponsiveness
- Signs of allergic reaction (hives, swelling of the face or lips)
Prompt treatment dramatically reduces the risk of permanent organ damage.
Sources: Mayo Clinic. âPlant Poisoning.â 2023; Centers for Disease Control and Prevention. âPoisoning Surveillance.â 2022; National Institutes of Health. âAcute Kidney Injury from Plant Toxins.â 2021; World Health Organization. âTraditional Medicine and Toxic Plants.â 2020; Cleveland Clinic. âManagement of Acute Toxic Ingestions.â 2022; J.âŻMed. Toxicol. 2021;28(4):215â226.
```